GI
GILD
HealthcareGilead Sciences, Inc.
Drug Manufacturers - General
Total Trades
13
Unique Traders
6
Purchases / Sales
9/4
News Articles
5
Trading History
| Date | Politician | Asset | Action | Amount | Trade Price | 30D Price | 1M Return | Alpha | 1M Prediction |
|---|---|---|---|---|---|---|---|---|---|
Apr 13, 2026 |  Rohit KhannaD | Stock | Sell | $15,001 - $50,000 | $139.03 | $133.05 | -4.3% | -12.5% | |
Jan 29, 2026 | Rohit KhannaD | Stock | Buy | $15,001 - $50,000 | $138.76 | $148.11 | +6.7% | +7.9% | |
Jan 27, 2026 |  Josh GottheimerD | Stock | Buy | $1,001 - $15,000 | $140.17 | $142.96 | +2.0% | +2.9% | |
Sep 23, 2025 |  Valerie HoyleD | Stock | Sell | $1,001 - $15,000 | $113.01 | $119.27 | +5.5% | +4.3% | |
Jun 6, 2025 |  Marjorie Taylor Greene | Stock | Buy | $1,001 - $15,000 | $110.17 | $110.25 | +0.1% | -4.6% | |
May 14, 2025 | Josh GottheimerD | Stock | Sell | $1,001 - $15,000 | $95.83 | $107.89 | +12.6% | +11.0% | |
May 12, 2025 |  Jefferson ShreveR | Stock | Sell | $15,001 - $50,000 | $101.13 | $106.47 | +5.3% | +2.1% | |
May 5, 2025 | Marjorie Taylor Greene | Stock | Buy | $1,001 - $15,000 | $100.15 | $106.20 | +6.0% | +0.3% | |
Mar 31, 2025 | Jefferson ShreveR | Stock | Buy | $15,001 - $50,000 | $109.15 | $103.78 | -4.9% | -4.1% | |
Mar 10, 2025 |  Carol Devine MillerR | Stock | Buy | $1,001 - $15,000 | $114.02 | $103.11 | -9.6% | -7.7% | |
Mar 7, 2025 | Josh GottheimerD | Stock | Buy | $1,001 - $15,000 | $114.22 | $105.07 | -8.0% | +4.0% | |
Oct 29, 2024 | Valerie HoyleD | Stock | Buy | $1,001 - $15,000 | $84.97 | $89.15 | +4.9% | +2.0% |
Recent News
Gilead Sciences (GILD) Declines More Than Market: Some Information for Investors
Yahoo-Invalid Date
Why Eli Lilly is betting $7B on this cancer drug
Yahoo-Invalid Date
Lightning Round: Biogen looks pretty darn good, says Jim Cramer
CNBC-Invalid Date
Gilead Sciences: Why I'm Tempted To Sell Ahead Of Q1 Earnings - But Won't
SeekingAlpha-Invalid Date
Arcus Biosciences Discontinues Lung Cancer Trial With Gilead
Finnhub-Invalid Date